BackOrion Biotech Opportunities - Warrants (15/04/2025) Overview

Orion Biotech Opportunities - Warrants (15/04/2025) Other Current Assets

Orion Biotech Opportunities - Warrants (15/04/2025)'s other current assets is $170K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$173603.00
72.90% YoYΔ $-466956.00 vs prior year quarter

Peer average / median

Loading

Orion Biotech Opportunities - Warrants (15/04/2025) Other Current Assets History

Loading

Orion Biotech Opportunities - Warrants (15/04/2025) vs. peers: Other Current Assets Comparison

Loading

Orion Biotech Opportunities - Warrants (15/04/2025) Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orion Biotech Opportunities - Warrants (15/04/2025) (ORIAW) FAQ

The latest other current assets for ORIAW is $170K as of December 2022. That compares with $640K in the prior-year period — down 72.9% year over year. Investors often review this figure alongside Orion Biotech Opportunities - Warrants (15/04/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ORIAW's other current assets moved from $640K to $170K — a 72.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orion Biotech Opportunities - Warrants (15/04/2025)'s operating scale or balance-sheet position.

A other current assets figure of $170K for ORIAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ORIAW's other current assets ($170K), review year-over-year change from $640K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.